Cargando…

Early defect of transforming growth factor β(1) formation in Huntington’s disease

A defective expression or activity of neurotrophic factors, such as brain- and glial-derived neurotrophic factors, contributes to neuronal damage in Huntington’s disease (HD). Here, we focused on transforming growth factor-β (TGF-β(1)), a pleiotropic cytokine with an established role in mechanisms o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Battaglia, Giuseppe, Cannella, Milena, Riozzi, Barbara, Orobello, Sara, Maat-Schieman, Marion L, Aronica, Eleonora, Busceti, Carla Letizia, Ciarmiello, Andrea, Alberti, Silvia, Amico, Enrico, Sassone, Jenny, Sipione, Simonetta, Bruno, Valeria, Frati, Luigi, Nicoletti, Ferdinando, Squitieri, Ferdinando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2011
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922377/ https://www.ncbi.nlm.nih.gov/pubmed/20082658 http://dx.doi.org/10.1111/j.1582-4934.2010.01011.x

Ejemplares similares

Aripiprazole in the treatment of Huntington’s disease: a case series
por: Ciammola, Andrea, et al.
Publicado: (2009)

Changes of peripheral TGF-β1 depend on monocytes-derived macrophages in Huntington disease
por: Di Pardo, Alba, et al.
Publicado: (2013)

DNA instability in replicating Huntington's disease lymphoblasts
por: Cannella, Milena, et al.
Publicado: (2009)

Pridopidine, a dopamine stabilizer, improves motor performance and shows neuroprotective effects in Huntington disease R6/2 mouse model
por: Squitieri, Ferdinando, et al.
Publicado: (2015)

Dickkopf-3 Upregulates VEGF in Cultured Human Endothelial Cells by Activating Activin Receptor-Like Kinase 1 (ALK1) Pathway
por: Busceti, Carla L., et al.
Publicado: (2017)

Genetic Counseling in Huntington's Disease: Potential New Challenges on Horizon?
por: Migliore, Simone, et al.
Publicado: (2019)

Profile of pridopidine and its potential in the treatment of Huntington disease: the evidence to date
por: Squitieri, Ferdinando, et al.
Publicado: (2015)

Targeting type-2 metabotropic glutamate receptors to protect vulnerable hippocampal neurons against ischemic damage
por: Motolese, Marta, et al.
Publicado: (2015)

Nitric Oxide Dysregulation in Platelets from Patients with Advanced Huntington Disease
por: Carrizzo, Albino, et al.
Publicado: (2014)

Safer Attitude to Risky Decision-Making in Premanifest Huntington’s Disease Subjects
por: D’Aurizio, Giulia, et al.
Publicado: (2019)

Genetic deletion of mGlu2 metabotropic glutamate receptors improves the short-term outcome of cerebral transient focal ischemia
por: Mastroiacovo, Federica, et al.
Publicado: (2017)

Sleep Quality and Related Clinical Manifestations in Huntington Disease
por: Maffi, Sabrina, et al.
Publicado: (2022)

Current Diagnostic Methods and Non-Coding RNAs as Possible Biomarkers in Huntington’s Disease
por: Pellegrini, Miguel, et al.
Publicado: (2022)

Deep White Matter in Huntington's Disease
por: Phillips, Owen, et al.
Publicado: (2014)

Developmental up-regulation of NMDA receptors in the prefrontal cortex and hippocampus of mGlu5 receptor knock-out mice
por: Imbriglio, Tiziana, et al.
Publicado: (2021)

Correction to: Developmental up-regulation of NMDA receptors in the prefrontal cortex and hippocampus of mGlu5 receptor knock-out mice
por: Imbriglio, Tiziana, et al.
Publicado: (2021)

Emotion recognition and inhibitory control in manifest and pre-manifest Huntington's disease: evidence from a new Stroop task
por: Hünefeldt, Thomas, et al.
Publicado: (2020)

Activation of mGlu3 Receptors Stimulates the Production of GDNF in Striatal Neurons
por: Battaglia, Giuseppe, et al.
Publicado: (2009)

Tractography of the Corpus Callosum in Huntington’s Disease
por: Phillips, Owen, et al.
Publicado: (2013)

Current Pharmacological Management in Juvenile Huntington’s Disease
por: Robertson, Lisa, et al.
Publicado: (2012)

Mitochondrial Respiration Changes in R6/2 Huntington’s Disease Model Mice during Aging in a Brain Region Specific Manner
por: Burtscher, Johannes, et al.
Publicado: (2020)

Major Superficial White Matter Abnormalities in Huntington's Disease
por: Phillips, Owen R., et al.
Publicado: (2016)

Induction of the Wnt Antagonist Dickkopf-1 Is Involved in Stress-Induced Hippocampal Damage
por: Matrisciano, Francesco, et al.
Publicado: (2011)

N-Acetyl-cysteine causes analgesia by reinforcing the endogenous activation of type-2 metabotropic glutamate receptors
por: Bernabucci, Matteo, et al.
Publicado: (2012)

Counterfactual Thinking Deficit in Huntington’s Disease
por: Solca, Federica, et al.
Publicado: (2015)

Regenerative Approaches in Huntington’s Disease: From Mechanistic Insights to Therapeutic Protocols
por: Sassone, Jenny, et al.
Publicado: (2018)

Cognitive and behavioral associated changes in manifest Huntington disease: A retrospective cross‐sectional study
por: Migliore, Simone, et al.
Publicado: (2021)

Lack or Inhibition of Dopaminergic Stimulation Induces a Development Increase of Striatal Tyrosine Hydroxylase-Positive Interneurons
por: Busceti, Carla Letizia, et al.
Publicado: (2012)

Analgesia induced by the epigenetic drug, L-acetylcarnitine, outlasts the end of treatment in mouse models of chronic inflammatory and neuropathic pain
por: Notartomaso, Serena, et al.
Publicado: (2017)

Chronic treatment with corticosterone increases the number of tyrosine hydroxylase-expressing cells within specific nuclei of the brainstem reticular formation
por: Busceti, Carla Letizia, et al.
Publicado: (2022)

International Guidelines for the Treatment of Huntington's Disease
por: Bachoud-Lévi, Anne-Catherine, et al.
Publicado: (2019)

Diagnostic properties of the Frontal Assessment Battery (FAB) in Huntington’s disease
por: Solca, Federica, et al.
Publicado: (2022)

“Spazio Huntington”: Tracing the Early Motor, Cognitive and Behavioral Profiles of Kids with Proven Pediatric Huntington Disease and Expanded Mutations > 80 CAG Repeats
por: Graziola, Federica, et al.
Publicado: (2022)

Naïve Huntington’s disease microglia mount a normal response to inflammatory stimuli but display a partially impaired development of innate immune tolerance that can be counteracted by ganglioside GM1
por: Steinberg, Noam, et al.
Publicado: (2023)

Cognitive Reserve in Early Manifest Huntington Disease Patients: Leisure Time Is Associated with Lower Cognitive and Functional Impairment
por: Migliore, Simone, et al.
Publicado: (2022)

Defining the role of the Bcl-2 family proteins in Huntington's disease
por: Sassone, J, et al.
Publicado: (2013)

The Autophagy-Related Organelle Autophagoproteasome Is Suppressed within Ischemic Penumbra
por: Biagioni, Francesca, et al.
Publicado: (2021)

Brain Overexpression of Uncoupling Protein-2 (UCP2) Delays Renal Damage and Stroke Occurrence in Stroke-Prone Spontaneously Hypertensive Rats
por: Busceti, Carla L., et al.
Publicado: (2020)

Differential modulation of AMPK/PPARα/UCP2 axis in relation to hypertension and aging in the brain, kidneys and heart of two closely related spontaneously hypertensive rat strains
por: Rubattu, Speranza, et al.
Publicado: (2015)

Increased Heat Pain Tolerance but Hyperalgesia to Tonic Inflammatory Pain in the CRND8 Mouse Model of Alzheimer’s Disease
por: Merlo, Sara, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_et46v9josv1f1obctfqitnm5pj